Literature DB >> 19669355

Spontaneous relapse of hepatitis in inactive HBsAg carriers.

Chia-Ming Chu1, Yun-Fan Liaw.   

Abstract

BACKGROUND/AIMS: The issue of spontaneous relapse of hepatitis in anti-HBe positive asymptomatic HBsAg carriers was rarely reported before and deserves further exploration.
METHODS: A total of 1241 anti-HBe positive asymptomatic adult HBsAg carriers were prospectively followed up. Of these, 661 (53%) were males, and the mean (+/-SD) age was 35.6 +/- 9.1 years. Relapse of hepatitis was defined as elevation of ALT more than twice the upper limit of normal accompanied by detectable serum HBV DNA by hybridization assays.
RESULTS: During a mean follow up of 12.3 years, hepatitis relapsed in 211 patients with an annual rate of 1.46%. The cumulative probabilities of hepatitis relapse were 10.2%, 17.4%, 19.3%, 20.2%, and 20.2%, respectively, after 5, 10, 15, 20, and 25 years of follow up. Multivariate analyses showed that the probability of hepatitis relapse correlated significantly with male sex (P < 0.0001) and age at entry (P = 0.007). The cumulative probability of hepatitis relapse after 20 years was 26.9% for males and only 12.5% for females, and was 13.1% for those of age <30 years at entry but increased to 29.4% for those of age 40-49 years at entry.
CONCLUSION: Hepatitis relapsed in about 20% of asymptomatic HBsAg carries during 25 years of follow up. Relapse of hepatitis occurred more frequently during earlier years of follow up. Males were more likely to have relapse of hepatitis than females. In addition, relapse of hepatitis was significantly less frequent in patients who were younger than 30 years at study entry, possibly implicating more favorable outcome of earlier HBeAg seroconversion.

Entities:  

Year:  2007        PMID: 19669355      PMCID: PMC2716824          DOI: 10.1007/s12072-007-9002-9

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  18 in total

1.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Authors:  Chien-Jen Chen; Hwai-I Yang; Jun Su; Chin-Lan Jen; San-Lin You; Sheng-Nan Lu; Guan-Tarn Huang; Uchenna H Iloeje
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

2.  A seroepidemiologic study of hepatitis B virus infection in Taiwan.

Authors:  D S Chen; J L Sung; M Y Lai
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1978-12

3.  Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study.

Authors:  D Y Lin; I S Sheen; C T Chiu; S M Lin; Y C Kuo; Y F Liaw
Journal:  J Clin Ultrasound       Date:  1993-06       Impact factor: 0.910

4.  Hepatitis B virus infection in Taiwan with reference to anti-HBc versus HBsAg and anti-HBs.

Authors:  J S Wu; C H Chen; Y H Chiang; Y C Lee; M H Lee; Y C Ko; H T Hu
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1980-09

5.  Natural history and prognostic factors for chronic hepatitis type B.

Authors:  G Fattovich; L Brollo; G Giustina; F Noventa; P Pontisso; A Alberti; G Realdi; A Ruol
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

6.  Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

Authors:  M-F Yuen; H-J Yuan; D K-H Wong; J C-H Yuen; W-M Wong; A O-O Chan; B C-Y Wong; K-C Lai; C-L Lai
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

7.  The development of cirrhosis in patients with chronic type B hepatitis: a prospective study.

Authors:  Y F Liaw; D I Tai; C M Chu; T J Chen
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

8.  Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.

Authors:  C M Chu; P Karayiannis; M J Fowler; J Monjardino; Y F Liaw; H C Thomas
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

9.  Sex difference in chronic hepatitis B virus infection: an appraisal based on the status of hepatitis B e antigen and antibody.

Authors:  C M Chu; Y F Liaw; I S Sheen; D Y Lin; M J Huang
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

10.  Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriers.

Authors:  C M Chu; I S Sheen; S M Lin; Y F Liaw
Journal:  Clin Infect Dis       Date:  1993-05       Impact factor: 9.079

View more
  19 in total

1.  Towards a rational treatment strategy for chronic hepatitis B.

Authors:  Yun-Fan Liaw
Journal:  Hepatol Int       Date:  2007-06-06       Impact factor: 6.047

2.  Unrevealing the natural course of the so-called "inactive HBsAg or HBV carrier state".

Authors:  Stephanos J Hadziyannis
Journal:  Hepatol Int       Date:  2007-06       Impact factor: 6.047

Review 3.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

Review 4.  Natural history of chronic hepatitis B: phases in a complex relationship.

Authors:  Catherine M N Croagh; John S Lubel
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a.

Authors:  Ming-Hui Li; Yao Xie; Lu Zhang; Yao Lu; Ge Shen; Shu-Ling Wu; Min Chang; Cai-Qin Mu; Lei-Ping Hu; Wen-Hao Hua; Shu-Jing Song; Shu-Feng Zhang; Jun Cheng; Dao-Zhen Xu
Journal:  World J Hepatol       Date:  2016-05-28

6.  The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study.

Authors:  Takashi Taida; Makoto Arai; Tatsuo Kanda; Shuhei Hige; Yoshiyuki Ueno; Fumio Imazeki; Namiki Izumi; Eiji Tanaka; Noboru Shinkai; Kentaro Yoshioka; Yasunari Nakamoto; Shuhei Nishiguchi; Masataka Tsuge; Masanori Abe; Michio Sata; Hiroshi Yatsuhashi; Akio Ido; Kazuhiko Kita; Ryousaku Azemoto; Yoshio Kitsukawa; Nobuaki Goto; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2016-06-15       Impact factor: 7.527

7.  HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B.

Authors:  Yun-Fan Liaw
Journal:  Hepatol Int       Date:  2009-06-24       Impact factor: 6.047

8.  Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update.

Authors:  Yun-Fan Liaw; Nancy Leung; Jia-Horng Kao; Teerha Piratvisuth; Edward Gane; Kwang-Hyub Han; Richard Guan; George K K Lau; Stephen Locarnini
Journal:  Hepatol Int       Date:  2008-05-10       Impact factor: 6.047

9.  Nuclear export and import of human hepatitis B virus capsid protein and particles.

Authors:  Hung-Cheng Li; Er-Yi Huang; Pei-Yi Su; Szu-Yao Wu; Ching-Chun Yang; Young-Sun Lin; Wen-Chang Chang; Chiaho Shih
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

10.  Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection.

Authors:  Qunying Han; Na Li; Qianqian Zhu; Zhu Li; Guoyu Zhang; Jinghong Chen; Yi Lv; Yawen Wang; Zhengwen Liu; Chunqiu Hao
Journal:  Clin Exp Med       Date:  2012-09-25       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.